Hedonia’s Mood Bloom™ Generates Outsized Return on Investment Potential in New Economic Study with Arbital Health

Content of the article

NEW YORK – Hedonia, an innovator in mobile mental health solutions, has revealed new findings from a new economic model showing that Hedonia has the potential to generate a 5:1 return on investment (ROI) for employers, payers, and healthcare solution providers.

The study, conducted in partnership with Arbital Health, a technology company that aims to manage the complexity of design, measurement and adjudication of value-based contracts, shows that using Hedonia’s digital therapy tool, Mood Bloom™, designed to treat depression and anxiety, has the potential to reduce cost and provide exceptional ROI.

Content of the article

The model is based on peer-reviewed findings from the Hedonia clinical trial at Massachusetts General Hospital. The clinical trial reported, among other findings, a 45% reduction in depressive symptoms, further supporting the app’s ability to increase clinical and financial improvement.

For example, a 20,000-person organization that offers the Hedonia therapeutic game app to its members can expect total cost savings of more than half a million dollars per year. This level of cost savings and ROI is a result of Mood Bloom’s high level of engagement, which is higher than the industry standard.

Mood Bloom is built on a proprietary therapeutic approach called Facilitating Thought Progression (FTP). FTP uses simple exercises to create new mental habits that can reduce symptoms of depression. This FTP-based training is embedded in a fun and exciting gaming experience. This unique approach of science-plus-game has been shown to increase engagement, thus adherence.

Other Key Findings include:

• Members with depression or anxiety are charged twice as much for health care compared to individuals without these mental health conditions.
• At least 20% of the total health costs which is directly related to mental health care, shows the financial burden of mental health places on employers and insurance.
• Owner members Chronic conditions such as depression or anxiety account for 40% of total treatment costsfurther exacerbating the economic impact.
• Transition the patient to a less severe mental health state through Mood Bloom results in measurable cost savings.

The economic model of the study, developed by Arbital Health, calculates the ROI by estimating the financial savings associated with Mood Bloom’s ability to improve mental health outcomes. The model shows that employers can realize significant cost reductions by using the Hedonia program, which transitions patients from more severe mental illness to less severe conditions, thereby reducing overall treatment costs.

“This study confirms what we have long believed: effective mental health solutions with low barriers to entry like Mood Bloom can not only improve patient outcomes but also generate significant financial returns for employers,” he said. Samuel KeretChief Executive Officer of Hedonia. “We are excited to see the real impact of our application, both in terms of patient health and economic savings.”

Content of the article

Content of the article

Ian Duncan, Chief Actuary at Arbital Health, commented, “The economic model built with Hedonia provides a useful tool for entrepreneurs looking to reduce the financial burden of mental health conditions. By using peer-reviewed outcome data and clinical findings, we were able to create a calculator Customizable ROI that can be tailored to different employer populations, so they can see potential cost savings right away.

The study used data from the MarketScan 2022 Database, analyzing spending patterns among members diagnosed with depression and anxiety. It examines the financial impact of Mood Bloom using detailed cost estimates from large US employers, demonstrating the program’s capacity to improve mental health outcomes while significantly reducing costs.

Additional Highlights:

• These programs show the highest potential savings in populations with high rates of depression, anxiety, and chronic conditions. It should be noted that depression and anxiety are often not detected or reported. Therefore, the impact of programs like Mood Bloom may be even higher than model reports, when offered to the entire membership base.
• 25% of members with chronic conditions (such as diabetes, COPD, and heart disease) are also diagnosed with depression or anxiety, providing a clear opportunity for Mood Bloom to positively influence mental and physical health outcomes.

A reduction in symptoms of depression and anxiety can have additional benefits outside of medical costs, such as cost savings that come from increased productivity. According to a study in the Annals of Family Medicine, the loss of productivity (presenteeism + absenteeism) goes from 29% for people with mild depression to 51% loss of productivity for people with severe depression. As members transition to a less severe state of mental health, productivity increases.

With mental health disorders on the rise, Hedonia’s Mood Bloom offers scalable, cost-effective, and cost-effective solutions for employers aiming for employee well-being while controlling healthcare costs.

About Hedonia: Hedonia is a leader in digital mental health innovation, offering evidence-based mobile tools that help treat depression and anxiety through a science-driven approach. Our flagship product, Mood Bloom™, combines mental health care with game design to drive engagement and improve results. hedonia.io.

Content of the article

For more information about Hedonia’s Mood Bloom and to study the economic model, please contact:
Annie Chadwick, Chief Commercial Officer
annie@hedonia.io

About Orbital Health: Arbital Health’s vision is to be a neutral third-party arbiter of outcomes-based contracting, unlocking and accelerating the $1 trillion shift to value-based care in the US healthcare system. We want to be the trusted arbiter that decides every outcome-based contract in health care, whether the contract is between a life science company and a payer, a payer and a provider, or an employer and a digital health company. We will make it easy to adjudicate contracts and unlock a trillion-dollar shift to value-based care. By doing so, we will help solve the biggest health problems.

For more information on the Arbital Health Platform and Actuarial Science Consulting that supports the creation, measurement and adjudication of value-based contracts, please contact learnmore@arbitalhealth.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20241103870211/en/

Ignition

Media Contact for Hedonia
Annie Chadwick, Chief Commercial Officer
annie@hedonia.io

Media Contact for Arbitration Health
Jessica Freeman
press@arbitalhealth.com

#distro

Content of the article